Rami Al-Jafar

Mr. Rami Al-Jafar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
RARami Al-Jafar
Rami Al-Jafar
MTMaria Zografou Themeli
Maria Zografou Themeli
SZSadia Zaman
Sadia Zaman
SASharmin Akbar
Sharmin Akbar
VLVictor Lhoste
Victor Lhoste
ADAbbas Dehghan
Abbas Dehghan
Background: Ramadan fasting is practiced by hundreds of millions every year. This ritual practice changes diet and lifestyle dramatically; thus, the effect of Ramadan fasting on blood pressure must be determined. Methods and Results: LORANS (London Ramadan Study) is an observational study, systematic review, and meta‐analysis. In LORANS, we measured systolic blood pressure (SBP) and diastolic blood pressure (DBP) of 85 participants before and right after Ramadan. In the systematic review, studies were retrieved from PubMed, Embase, and Scopus from inception to March 3, 2020. We meta‐analyzed the effect from these studies and unpublished data from LORANS. We included observational studies that measured SBP and/or DBP before Ramadan and during the last 2 weeks of Ramadan or the first 2 weeks of the month after. Data appraisal and extraction were conducted by at least 2 reviewers in parallel. We pooled SBP and DBP using a random‐effects model. The systematic review is registered with PROSPERO (International Prospective Register of Systematic Reviews; CRD42019159477). In LORANS, 85 participants were recruited; mean age was 45.6±15.9 years, and 52.9% ( n =45) of participants were men. SBP and DBP after Ramadan fasting were lower by 7.29 mm Hg (−4.74 to −9.84) and 3.42 mm Hg (−1.73 to −5.09), even after adjustment for potential confounders. We identified 2778 studies of which 33 with 3213 participants were included. SBP and DBP after/before Ramadan were lower by 3.19 mm Hg (−4.43 to −1.96, I 2 =48%) and 2.26 mm Hg (−3.19 to −1.34, I 2 =66%), respectively. In subgroup analyses, lower blood pressures were observed in the groups who are healthy or have hypertension or diabetes but not in patients with chronic kidney disease. Conclusions: Our study suggests beneficial effects of Ramadan fasting on blood pressure independent of changes in weight, total body water, and fat mass and supports recommendations for some governmental guidelines that describe Ramadan fasting as a safe religious practice with respect to blood pressure.

17 January 2023 in Frontiers in Nutrition
Verified
Journal Article
Open access
RARami Al-Jafar
Rami Al-Jafar
NWNisa Sri Wahyuni
Nisa Sri Wahyuni
KBKarim Belhaj
Karim Belhaj
MEMohammad Hamed Ersi
Mohammad Hamed Ersi
ZBZahra Boroghani
Zahra Boroghani
ADAbbas Dehghan
Abbas Dehghan
Background: Although the effect of Ramadan intermittent fasting (RIF) on anthropometry and body composition has been questioned, none of the previous studies tried to explain the reported changes in these parameters. Also, systematic reviews that investigated the topic were limited to healthy individuals or a specific disease group.Methods: The London Ramadan Study (LORANS) is an observational study on health effects of RIF. We measured weight, waist circumference (WC), hip circumference (HC), body mass index (BMI), waist-to-hip ratio (WHR), basal metabolic rate (BMR), fat percentage (FP), free-fat mass (FFM), extremities predicted muscle mass, total body water (TBW), trunk FM, trunk FFM and trunk predicted muscle mass before and immediately after Ramadan. Using mixed-effects regression models, we investigated the effect of RIF with adjustment for potential confounders. We also conducted a meta-analysis of the results of LORANS with other studies that investigated the effect of RIF on anthropometry and body composition. The review protocol is registered with PROSPERO registry (CRD42020186532).Results: We recruited 146 participants (Mean ± SD age = 43.3 ± 15 years). Immediately after Ramadan, compared with before Ramadan, the mean difference was−1.6 kg (P<0.01) in weight,−1.95cm (P<0.01) in WC,−2.86cm (P <0.01) in HC, −0.60 kg/m2 (P < 0.01) in BMI and −1.24 kg (P < 0.01) in FM. In the systematic review and meta-analysis, after screening 2,150 titles and abstracts, 66 studies comprising 7,611 participants were included. In the general population, RIF was followed by a reduction of 1.12 Kg in body weight (−1.89– −0.36, I2 = 0), 0.74 kg/m2 reduction in BMI (−0.96– −0.53, I2 = 0), 1.54cm reduction in WC (−2.37– −0.71, I2 = 0) and 1.76cm reduction in HC (−2.69– −0.83, I2 = 0). The effect of fasting on anthropometric and body composition parameters starts to manifest in the second week of Ramadan and starts to diminish 3 weeks after Ramadan.Conclusion: RIF is associated with a reduction in body weight, BMI, WC, HC, FM, FP and TBW. Most of these reductions are partially attributed to reduced FM and TBW. The reductions in these parameters appear to reverse after Ramadan.

1 February 2024 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
RARami Al-Jafar
Rami Al-Jafar
RPRui Climaco Pinto
Rui Climaco Pinto
PEPaul Elliott
Paul Elliott
KTKonstantinos K Tsilidis
Konstantinos K Tsilidis
ADAbbas Dehghan
Abbas Dehghan
The dramatic change in lifestyle associated with Ramadan fasting raises questions about its effect on metabolism and health. Metabolites, as the end product of metabolism, are excellent candidates to be studied in this regard. This study aims to investigate the effect of Ramadan fasting on the metabolic profile and risk of chronic diseases. The London Ramadan study (LORANS) is an observational study in which 2 blood samples were collected from 72 participants a few days before and after the fasting month of Ramadan. We conducted metabolomic profiling using nuclear magnetic resonance spectroscopy to assess the change in individual metabolites from before to after Ramadan. Also, we generated metabolic scores (scaled from 0 to 100) for 7 chronic diseases in the UK Biobank and assessed the association of Ramadan fasting with these scores in LORANS. Of the 72 participants, 35 were male (48.6%); the mean (± standard deviation) age was 45.7 (±16) y. Ramadan fasting was associated with changes in 14 metabolites (1 inflammation marker, 1 amino acid, 2 glycolysis-related metabolites, 2 ketone bodies, 2 triglyceride, and 6 lipoprotein subclasses), independent of changes in body composition. Using data from 117,981 participants in the UK Biobank, we generated metabolic scores for diabetes, hypertension, coronary artery disease, renal failure, colorectal cancer, breast cancer, and lung cancer. The metabolic scores for lung cancer, colorectal cancer, and breast cancer were lower after Ramadan in LORANS (-4.74, 9.6%, 95% confidence interval -6.56, -2.91, P < 0.001), (-1.09, -2.4%, -1.69, -0. 50, P < 0.001), and (-0.48, -1.1%, -0. 81, -0.15, P = 0.006), respectively. Ramadan fasting is associated with short-term favorable changes in the metabolic profile concerning risk of some chronic diseases. These findings should be further investigated in future, larger studies of longer follow-up with clinical outcomes.

10 June 2024 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
RARami Al-Jafar
Rami Al-Jafar
WYWang Yuqi
Wang Yuqi
PEPaul Elliott
Paul Elliott
KTKonstantinos K. Tsilidis
Konstantinos K. Tsilidis
ADAbbas Dehghan
Abbas Dehghan
Background: The effect of Ramadan intermittent fasting (RIF) on the metabolic profile, anthropometry and blood pressure has been investigated in multiple studies. However, it is still unknown to what extent changes in nutrient intakes contribute to these changes.Methods: This observational study was conducted in London (UK) in 2019. The study collected diverse data from a community-based sample in London before and during/after Ramadan. Collected data included a 3-day food diary (before and during Ramadan), as well as blood samples, anthropometric measurements and blood pressure (before and after Ramadan). The food diary was translated into nutritional data using nutrition software “Nutritics.” The changes in nutrient intakes were investigated using a mixed-effects regression model. The impact of adjusting for nutrient intake change was investigated on the absolute difference of metabolites (Nightingale platform), systolic/diastolic blood pressure and anthropometric measures.Results: The study collected data on food intake before and during Ramadan from 56 participants; the mean age was 44.7 ± 17.3, and 51.8% (n = 29) were females. We found a change in the intake of 11 nutritional factors, glucose, fructose, betaine, sugars, sugars as monosaccharide equivalents, lutein/zeaxanthin, starch, starch as monosaccharide equivalents, proline, glutamic acid and lycopene. No changes in quantities or proportions of macronutrients, carbohydrates, protein and fat. Mainly, the changes in diet during Ramadan are characterized by more consumption of sugars (62%, p < 0.001) and a lower intake of starch (−21%, p = 0.012). The changes in 14 metabolite levels (two glycolysis-related metabolites, one amino acid, two ketone bodies, two triglyceride, six lipoprotein subclasses, and an inflammation marker) after Ramadan were partially associated with some changes in nutrient intakes during Ramadan, especially betaine, fructose, glucose, starches and sugars. The lutein/zeaxanthin intake change explained inversely 14% of systolic blood pressure changes. Moreover, BMI and weight changes were partially explained by changes in intake of fat (7%; 9%), monounsaturated fat (6%; 7%), starch (8%; 9%), and starch as monosaccharide equivalents (8%; 9%) intakes in a direct relationship.Conclusion: Diet changes during Ramadan were associated partially with the observed changes in the metabolic profile, blood pressure and anthropometry. This confirms the changes associated with RIF in the metabolic profile, blood pressure and anthropometry are not an absolute physiological response to the diet transition occurring during Ramadan.

16 July 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RARami Al-Jafar
Rami Al-Jafar
PEPaul Elliott
Paul Elliott
KTKonstantinos K. Tsilidis
Konstantinos K. Tsilidis
ADAbbas Dehghan
Abbas Dehghan
Background Hundreds of millions of Muslims fast during the month of Ramadan. The London Ramadan Fasting Study (LORANS) aims to assess the lifestyle changes during this month and investigate the effect of Ramadan fasting on health. Methods LORANS is an observational study of participants that follow religious fasting in Ramadan. We advertised, recruited, and visited participants in five mosques in London, United Kingdom. In total, 146 individuals were recruited before Ramadan in May 2019 of which 85 participated in the follow up visit after Ramadan. The study protocol was approved by the ethics committee affiliated to Imperial College London. A written informed consent was signed by all the participants. Every participant completed a questionnaire, a physical examination, and gave blood samples at each visit. Moreover, they completed a 3-day food diary before Ramadan and once again during Ramadan to record dietary changes during the month of fasting. Results The mean age of participants was 45.6± 15.9 years. 47.1% of the participants were females, 25.5% were obese, 4.7% were smokers, 14% were diabetic, 24% were hypertensive, and 5.2% had cardiovascular diseases. Data collection covered demographics, lifestyle, food intake, blood pressure, anthropometric measurements, body composition, and metabolic biomarker profiling. Conclusion By engaging with mosques, proper introduction of the study aims and convenient recruitment in the mosque, we were able to recruit a balanced population regarding age and sex and collected valuable data on Ramadan fasting using high-quality techniques.

6 May 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RARami Al-Jafar
Rami Al-Jafar
RARazan AlGhassab
Razan AlGhassab
HAHaya M. Alzeer
Haya M. Alzeer
AAAbdullah Al-Zeer
Abdullah Al-Zeer
MAMohammed Aldossary
Mohammed Aldossary
KAKhalid Alrajhi
Khalid Alrajhi
Background: Measuring the quality of life of a population provides a baseline for future comparisons and is essential for decision-makers, especially regarding resource allocation. Despite substantial investment in healthcare services in Saudi Arabia, no study has captured the general Saudi population’s overall health-related quality of life. This study utilized existing healthcare system data to develop reference values for the Patient-Reported Outcome Measurement Information System - Global Health (PROMIS-GH) survey for the population in Saudi Arabia and to examine associated sociodemographic predictors of health-related quality of life. Methods: From a nationwide survey conducted by the Saudi Ministry of Health, records of 40,000 out of 37,160,000 individuals were randomly selected with stratification for sex, age groups and regions. Participants received notifications via the national digital health platform (Sehhaty) to complete the PROMIS-GH survey. Results: A total of 3,630 individuals filled out the survey (response rate of 9.1%); the mean age was 38.6 ± 12.1 years, and 60.1% (n = 2182) were men. The general Saudi population had mean T-scores of 50.5 (± 10.3) for global mental health and 48.5 (± 9.8) for global physical health, both classified as “very good” based on the established Saudi-specific thresholds. Being Saudi or female was associated with lower physical and mental health scores. Conclusion: The health-related quality of life scores in Saudi Arabia are classified as “very good”; however, disparities exist. Future studies are needed to further investigate the reasons behind the sociodemographic and regional variations in HRQoL among the general population of Saudi Arabia.